Resources for caregivers, families and those living with
Alzheimer’s…click here for savings and values from the
line of products from Amazon.
Lifetime history of depression linked with more brain
plaques, tangles
Newswise — A lifetime
history of depression is associated with increased
plaques and tangles in the brains of those with
Alzheimer’s disease and more rapid cognitive decline,
according to a study in the February issue of Archives
of General Psychiatry, one of the JAMA/Archives
journals.
Previous studies have
linked depression and Alzheimer’s disease, according to
background information in the article. People with a
lifetime history of major depressive disorder (MDD) may
be more likely to be diagnosed with AD. In addition,
both AD and MDD are likely to affect the brain’s
memory-related temporal lobes. MDD is likely to caused
atrophy of the hippocampus, the area where the largest
amounts of plaques and tangles form in patients with AD,
the authors write.
To assess how MDD
might affect the development of AD, Michael A. Rapp,
M.D., Ph.D., Mount Sinai School of Medicine, New York,
and colleagues compared the brains of 44 AD patients
with a history of depression to those of 51 without. The
group included 32 men and 63 women with an average age
at death of 81 years.
Patients with a
history of depression had more tangles and plaques in
the hippocampus than those without, the authors report.
People who were depressed at the time they were
diagnosed with AD had even more pronounced changes in
their brains than those whose depression occurred
earlier or later. Based on analyses of cognitive tests
given during participants’ lifetimes, patients with AD
who had a history of depression also experienced a more
rapid decline into dementia than those who did not have
depression.
“These results have
great clinical significance in that the identification
of potential mechanisms that link geriatric MDD as a
treatable risk factor to neuropathological changes in AD
may lead to the development of differential intervention
and prevention strategies for AD,” the authors conclude.
“Such specific interventions would be especially needed
since geriatric patients with MDD with cognitive
impairment may have less favorable treatment outcomes.”